Literature DB >> 11421476

Surveillance of wild polioviruses in patients with acute flaccid paralysis in Malta during 1998 and 1999.

M Muscat1, L Fiore, R Busuttil, H M Gilles.   

Abstract

Certification of global poliomyelitis eradication can only be accomplished when all countries have been certified as having achieved wild poliovirus eradication. In order to achieve certification of eradication of poliomyelitis in Malta an active acute flaccid paralysis (AFP) surveillance system comprising the whole population was set up. Surveillance became effective in January 1998. During 1998, there were nine reported cases of AFP (non-polio AFP rate: 2.38 per 100,000 population) two of whom were children under 15 years of age (non-polio AFP rate: 2.52 per 100,000 for the population aged <15 years). In 1999 five cases of AFP were reported (non-polio AFP rate: 1.32 per 100,000 population). One case occurred in a child under 15 years (non-polio AFP rate: 1.28 per 100,000 for population aged <15 years). Virological investigation did not detect any wild or Sabin-like polioviruses.

Entities:  

Mesh:

Year:  2000        PMID: 11421476     DOI: 10.1023/a:1010848925903

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  2 in total

1.  Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority.

Authors:  Y Manor; R Handsher; T Halmut; M Neuman; A Bobrov; H Rudich; A Vonsover; L Shulman; O Kew; E Mendelson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Progress towards the global eradication of poliomyelitis.

Authors:  H F Hull; N A Ward
Journal:  World Health Stat Q       Date:  1992
  2 in total
  1 in total

1.  An epidemiological analysis of acute flaccid paralysis and its surveillance system in Iraq, 1997-2011.

Authors:  Jagar A Jasem; Kawa Marof; Adnan Nawar; Yosra Khalaf; Faisal Al-Hamdani; Sagvan Ali; Andre C Kalil; K M Monirul Islam
Journal:  BMC Infect Dis       Date:  2014-08-20       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.